Internship

Intern – Regulatory Affairs

Oncology

Confirmed live in the last 24 hours

Gilead Sciences

Gilead Sciences

10,001+ employees

Develops and commercializes biopharmaceuticals

Biotechnology
Healthcare

Compensation Overview

$19 - $55Hourly

No H1B Sponsorship

San Mateo, CA, USA

Must be able to relocate if necessary and work at the designated site for the duration of the internship.

Category
Risk & Compliance
Legal & Compliance
Requirements
  • Must be at least 18 years old
  • Must have a minimum GPA of 2.8
  • Authorized to work in the United States without Sponsorship now or in the future or CPT/OPT through your University.
  • Must be currently enrolled as a full-time student in a Bachelor’s/Masters/MBA/PhD program at an accredited US based university or college
  • Must be a Rising Sophomore, Junior, or Senior in undergrad or a Graduate or Doctoral Student
  • Must be enrolled full-time in the Fall Semester at an accredited university/college after the completion of the internship
  • Must be able to complete a 10-12 consecutive week internship between May and August
  • Must be able to relocate if necessary and work at the designated site for the duration of the internship
Responsibilities
  • Interns will assist the Global Regulatory Affairs Oncology Liaison team with projects to support department goals and objectives.
  • Interns will assist with development and submission of regulatory documents such as clinical study reports, study protocols and protocol amendments, and assist with activities in preparation for annual reporting requirements (e.g., Investigator Brochure, Orphan Annual report, etc.).
  • In addition, the intern work across the global regulatory network on various research projects and present their findings at team meeting and a final poster board presentation at the conclusion of their internship

Gilead Sciences is a biopharmaceutical company that develops and sells medicines for various serious health conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then approved by regulatory authorities before being marketed to healthcare providers, hospitals, and pharmacies. Gilead distinguishes itself from competitors through its strong focus on R&D and strategic partnerships, such as its collaboration with SAP Ariba to improve supply chain processes. The company's goal is to enhance health equity and access to care, working with communities globally to ensure that its medicines reach those in need.

Company Stage

IPO

Total Funding

$15.9B

Headquarters

Foster City, California

Founded

1987

Simplify Jobs

Simplify's Take

What believers are saying

  • Gilead's investment in Xilio Therapeutics strengthens its position in immuno-oncology therapies.
  • Partnership with Terray Therapeutics diversifies Gilead's drug discovery approaches with small-molecule therapies.
  • Appointment of Dietmar Berger as CMO enhances leadership in clinical development and regulatory strategy.

What critics are saying

  • Increased competition in HIV treatment from ViiV Healthcare could impact Gilead's market share.
  • Regulatory scrutiny over drug pricing in the U.S. may affect Gilead's profit margins.
  • Ongoing patent litigation with Teva over Truvada could lead to financial liabilities.

What makes Gilead Sciences unique

  • Gilead's lenacapavir is recognized as a breakthrough in HIV care for 2024.
  • The company collaborates with Tubulis to develop innovative antibody-drug conjugates for cancer.
  • Gilead's strategic partnerships enhance its R&D capabilities and diversify its treatment portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options